Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Curis Lifesciences
|
Amwill Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.51 % | 63.11 % | 84.18 % |
|
5yr average Equity Multiplier
|
1.49 | 1.91 | 0.32 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 1.07 | 2.35 |
|
5yr Avg Net Profit Margin
|
6.6 % | 8.37 % | 13.8 % |
|
Price to Book
|
1.79 | 6.22 | 1.4 |
|
P/E
|
20.44 | 16.62 | 9.04 |
|
5yr Avg Cash Conversion Cycle
|
-4.69 Days | 45.79 Days | 115.9 Days |
|
Inventory Days
|
32.68 Days | 77.61 Days | 26.46 Days |
|
Days Receivable
|
115.65 Days | 65.45 Days | 133.46 Days |
|
Days Payable
|
157.73 Days | 245.93 Days | 129.03 Days |
|
5yr Average Interest Coverage Ratio
|
15.15 | 5.43 | 0.0 |
|
5yr Avg ROCE
|
13.49 % | 36.41 % | 102.76 % |
|
5yr Avg Operating Profit Margin
|
11.74 % | 16.92 % | 17.69 % |
|
5 yr average Debt to Equity
|
0.13 | 0.12 | 0.0 |
|
5yr CAGR Net Profit
|
-10.08 % | 65.64 % | 33.09 % |
|
5yr Average Return on Assets
|
7.02 % | 9.21 % | 26.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | n/a | 70.65 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Mercury Laboratories
|
Curis Lifesciences
|
Amwill Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|